LC Med is a general practice in Ecaussinnes. Private Limited, started on 1 August 2022, 1 establishment.

What is the address of LC Med?

The registered office of LC Med is located at Rue du Bois de Feluy 13A, 7190 Ecaussinnes.

Is LC Med still active?

Yes. According to the CBE (30 October 2026) LC Med is active, legal situation “Normale toestand”, started on 1 August 2022.

Is LC Med registered on Peppol?

Yes, LC Med is registered on the Peppol network with ID 0208:0789286525.

What is the enterprise number of LC Med?

The enterprise number of LC Med is BE0789286525.

When was LC Med founded?

LC Med was founded on 1 August 2022.

Who are the directors of LC Med?

According to the 2025 annual accounts, the directors of LC Med are: Christelle Lecomte.

Is LC Med a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 1 August 2022; 4 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did LC Med make in 2025?

LC Med posted a profit after taxes of € 43,571 in financial year 2025.

What is the revenue of LC Med?

As a small company, LC Med is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 61,747.

LC Med (Private Limited) - Ecaussinnes - BE0789286525

Dossier LC Med, printed on 30 October 2026 from databakkes.be/en/0789286525/lc-med. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

LC Med from Ecaussinnes, company number BE0789286525, closed financial year 2025 with a result of € 43,571 after tax. For that financial year LC Med recorded a gross margin of € 61,747 and equity of € 109,581. Compared with financial year 2024, the result moved from € 77,834 to € 43,571. The company is profitable. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 15, 2026.

What it is worth Healthy

€ 109,581

▼ 42% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 43,571

▼ 44% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 122,856

▼ 10% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 121,405 paid out

More than the year’s profit went to the shareholders; reserves fell.

People and assets in 2025

Full-time equivalents estimate The annual accounts report no full-time equivalents. A micro company with one active director is usually run by that person; this is an assumption, not a figure from the source.

≈ 1

No payroll staff. One director, so that person most likely runs the business.

Vehicles and equipment

€ 1,105

▼ 46% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 2,787

▼ 10% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 2,000

▼ 95% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 75,028 Gross margin 2022: € 75,028 First fiscal year in the series	€ 75,398 Gross margin 2023: € 75,398 Unchanged (€ 75,028) Favourable step	€ 99,799 Gross margin 2024: € 99,799 ▲ 32% vs 2023 (€ 75,398) Favourable step	€ 61,747 Gross margin 2025: € 61,747 ▼ 38% vs 2024 (€ 99,799) Unfavourable step	▼ 38%
Profit after taxes	€ 53,798 Profit after taxes 2022: € 53,798 First fiscal year in the series	€ 53,283 Profit after taxes 2023: € 53,283 ▼ 1% vs 2022 (€ 53,798) Unfavourable step	€ 77,834 Profit after taxes 2024: € 77,834 ▲ 46% vs 2023 (€ 53,283) Favourable step	€ 43,571 Profit after taxes 2025: € 43,571 ▼ 44% vs 2024 (€ 77,834) Unfavourable step	▼ 44%
Equity	€ 56,298 Equity 2022: € 56,298 First fiscal year in the series	€ 109,581 Equity 2023: € 109,581 ▲ 95% vs 2022 (€ 56,298) Favourable step	€ 187,415 Equity 2024: € 187,415 ▲ 71% vs 2023 (€ 109,581) Favourable step	€ 109,581 Equity 2025: € 109,581 ▼ 42% vs 2024 (€ 187,415) Unfavourable step	▼ 42%
Total debts	€ 9,440 Total debts 2022: € 9,440 First fiscal year in the series	€ 29,630 Total debts 2023: € 29,630 ▲ 214% vs 2022 (€ 9,440) Unfavourable step	€ 45,594 Total debts 2024: € 45,594 ▲ 54% vs 2023 (€ 29,630) Unfavourable step	€ 126,319 Total debts 2025: € 126,319 ▲ 177% vs 2024 (€ 45,594) Unfavourable step	▲ 177%
Cash	€ 23,920 Cash 2022: € 23,920 First fiscal year in the series	€ 69,450 Cash 2023: € 69,450 ▲ 190% vs 2022 (€ 23,920) Favourable step	€ 136,932 Cash 2024: € 136,932 ▲ 97% vs 2023 (€ 69,450) Favourable step	€ 122,856 Cash 2025: € 122,856 ▼ 10% vs 2024 (€ 136,932) Unfavourable step	▼ 10%
Retained profit	€ 53,798 Retained profit 2022: € 53,798 First fiscal year in the series	€ 107,081 Retained profit 2023: € 107,081 ▲ 99% vs 2022 (€ 53,798) Favourable step	€ 184,915 Retained profit 2024: € 184,915 ▲ 73% vs 2023 (€ 107,081) Favourable step	€ 107,081 Retained profit 2025: € 107,081 ▼ 42% vs 2024 (€ 184,915) Unfavourable step	▼ 42%
Dividend	€ 0 Dividend 2022: € 0 First fiscal year in the series	€ 0 Dividend 2023: € 0 Unchanged (€ 0) Unchanged	€ 0 Dividend 2024: € 0 Unchanged (€ 0) Unchanged	€ 121,405 Dividend 2025: € 121,405 Unchanged (€ 0) Unchanged
Balance sheet total	€ 65,738 Balance sheet total 2022: € 65,738 First fiscal year in the series	€ 139,211 Balance sheet total 2023: € 139,211 ▲ 112% vs 2022 (€ 65,738) Unchanged	€ 233,008 Balance sheet total 2024: € 233,008 ▲ 67% vs 2023 (€ 139,211) Unchanged	€ 235,900 Balance sheet total 2025: € 235,900 ▲ 1% vs 2024 (€ 233,008) Unchanged	▲ 1%

Key figures of LC Med, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to LC Med?

What happened at LC Med in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jul 15, 2026 New annual accounts for financial year 2025: profit of € 43,571 (▼ 44% vs 2024). Source: NBB ↗
Aug 1, 2022 New establishment in Ecaussinnes. KBO
2022 Christelle Lecomte became a director. NBB
Aug 1, 2022 Start of the company according to the CBE. KBO

In short

From € 53,798 profit in 2022 to € 43,571 profit in 2025.

Paid € 73,250 in corporate taxes since 2022.

Best year ever: 2024, with € 77,834 profit.

Paid out € 121,405 in dividends to the owners in total.

Original PDFs at the National Bank ↗

Management

Christelle Lecomte

LC Med

FELUYMED 25%

Behind LC Med is Christelle Lecomte. It owns 25% of FELUYMED itself.

Directors

According to the 2025 annual accounts

Christelle Lecomte

Director

Also active at: FeluyMed

since 2022

Establishments

Establishment units

Physical locations of this company

Registered office

Rue du Bois de Feluy 13A

7190 Ecaussinnes

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0789.286.525
VAT number: BE 0789.286.525
Registered office: Rue du Bois de Feluy 13A, 7190 Ecaussinnes
Names & denominations: LC Med
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 1 August 2022
Peppol: Active · Active since 7 Jan 2026
Activities · NACE: Activiteiten van huisartspraktijken

View on CBE Public ↗ Annual accounts (NBB) ↗